Webinar: Immune Response in Stem Cell-based Therapy

Return to CIRM Meetings and Events

Webinar: Immune Response in Stem Cell-based Therapy

Presentations from FDA and Leading Experts

Date: September 27, 2012 from 10 am to 12 noon (Pacific)

Below are links to recordings of the webinar as well as the speakers’ slides:

Links to recordings of the webinar:

Links to the webinar speakers’ presentation slides:

Moderator: Ellen Feigal, MD, Senior Vice President of Research and Development, CIRM


  • Theresa Chen, Ph.D., Pharmacology/Toxicology Reviewer, Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)
  • Heike Daldrup-Link, M.D., Associate Professor of Radiology, Stanford University School of Medicine
  • Amitabh Gaur, Ph.D., Director of Custom Technology, BD Biosciences

Topics covered:

  • Presentation by FDA – regulatory perspective on immune rejection concerns in the preclinical assessment of human cellular therapy products
  • Assessing immune response to stem cell transplants with clinically applicable imaging techniques
  • Assessing the immunogenicity of stem cells
  • Overcoming the immune rejection challenge
  • Questions and Answers

Background material:

Date Published: December 14, 2012
Last Modified: March 12, 2015